Report post

What is the target price for Enanta Pharmaceuticals (Enta) stock?

9 brokers have issued 12-month target prices for Enanta Pharmaceuticals' stock. Their ENTA share price forecasts range from $49.00 to $96.00. On average, they predict the company's stock price to reach $68.60 in the next twelve months. This suggests a possible upside of 87.5% from the stock's current price.

Who owns Enanta Pharmaceuticals Inc?

The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA. ENTA | Complete Enanta Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

What does Enanta Pharmaceuticals do?

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

The World's Leading Crypto Trading Platform

Get my welcome gifts